Lucid Ultra 128 vs Resound Vivia 9 60S microRIE

The Lucid Ultra 128 is a premium behind-the-ear prescription hearing aid priced at $5,000, earning an A grade with a SoundScore of 4.4/5 in our lab testing. It ranks #16 of 36 devices in the Prescription Hearing Aid category. Speech performance is a clear strength for the Ultra 128. In our testing, speech in quiet scored a strong 4.3/5, landing 1.03 points above the category average. Speech in noise measured 2.7/5—above the category average by 0.74 points, though mixed in absolute terms. These results suggest the device prioritizes intelligibility in everyday listening situations. The Ultra 128 does show notable weaknesses. Feedback handling scored just 1.7/5, falling 3.01 points below the category average of 4.71/5—a significant gap that prospective buyers should consider. Music streaming measured 2.3/5, slightly below the category average. Own-voice comfort was mixed at 2.9/5, though this sits just above the category norm. The device uses disposable batteries and supports streaming to both iPhone and Android. At this price point, buyers may want to compare against higher-scoring competitors like the Phonak Sphere Infinio (5.0/5) or Oticon Intent (4.85/5). The Lucid Ultra 128 may suit those who prioritize speech clarity in quieter environments and can work with their hearing care provider to manage its feedback limitations.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.